Strategies to improve adherence to medications for cardiovascular diseases in socioeconomically disadvantaged populations: A systematic review

International Journal of Cardiology

Volumn 167, Issue 6, 2013, Pages 2430-2440

  Laba, Tracey Lea ^a,b   Bleasel, Jonathan ^a,c   Brien, Jo Anne ^b,c,d   Cass, Alan ^a   Howard, Kirsten ^f   Peiris, David ^a   Redfern, Julie ^a,e   Salam, Abdul ^a   Usherwood, Tim ^e   Jan, Stephen ^a,e  

^a GEORGE INSTITUTE FOR GLOBAL HEALTH   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

^d ST VINCENT S HOSPITAL   (Australia)

^e UNIVERSITY OF SYDNEY   (Australia)

^f UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Cardiovascular disease; Medication adherence; Socioeconomic disadvantage

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOOP DIURETIC AGENT; SPIRONOLACTONE;

CARDIOVASCULAR DISEASE; CLINICAL EFFECTIVENESS; CLINICAL PRACTICE; COMMUNICATION DISORDER; COST CONTROL; COST EFFECTIVENESS ANALYSIS; DATA SYNTHESIS; DEMOGRAPHY; DISEASE CONTROL; DOCTOR PATIENT RELATION; EDUCATIONAL STATUS; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH CARE PLANNING; HEALTH CARE POLICY; HEALTH DISPARITY; HEALTH PROMOTION; HEART FAILURE; HUMAN; HYPERTENSION; MEDICATION COMPLIANCE; OCCUPATION; PATIENT CARE; PATIENT COMPLIANCE; POPULATION RESEARCH; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SOCIAL BEHAVIOR; SOCIAL STATUS; SOCIOECONOMICS; SYSTEMATIC REVIEW; TREATMENT OUTCOME; TREATMENT REFUSAL;

CARDIOVASCULAR DISEASE; MEDICATION ADHERENCE; SOCIOECONOMIC DISADVANTAGE;

CARDIOVASCULAR DISEASES; COST-BENEFIT ANALYSIS; HUMANS; MEDICATION ADHERENCE; SOCIOECONOMIC FACTORS; VULNERABLE POPULATIONS;

EID: 84883759820     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2013.01.049     Document Type: Review

References (42)

1. M.R. DiMatteo Variations in patients' adherence to medical recommendations: a quantitative review of 50 years of research Med Care 42 2004 200 209
2. E. Sabate Adherence to long term therapies: evidence for action (available at http://www.who.int/chronic-conditions/adherencereport/en/) 2003 World Health Organisation Geneva, Switzerland
3. K. Humphrey, T. Weeramanthri, and J. Fitz Forgetting compliance 2001 Northern Territory University Press
4. R.B. Haynes, E. Ackloo, N. Sahota, H.P. McDonald, and X. Yao Interventions for enhancing medication adherence [update of Cochrane Database Syst Rev. 2005;(4):CD000011; PMID: 16235271] Cochrane Database Syst Rev 2008 CD000011
5. M. Suhrcke, T.A. Boluarte, and L. Niessen A systematic review of economic evaluations of interventions to tackle cardiovascular disease in low- and middle-income countries BMC Public Health 12 2012 2
6. R. Horne, J. Weinman, N. Barber, R. Elliott, and M. Morgan Concordance, adherence and compliance in medicine taking Report for the National Co-ordinating Centre for NHS Delivery and Organisation R & D (NCCSDO) 2005
7. P. Pound, N. Britten, and M. Morgan Resisting medicines: a synthesis of qualitative studies of medicine taking Soc Sci Med 61 2005 133 155
8. E. Lehane, and G. McCarthy Intentional and unintentional medication non-adherence: a comprehensive framework for clinical research and practice? A discussion paper Int J Nurs Stud 44 2007 1468 1477
9. S.C. Kalichman, and T. Grebler Stress and poverty predictors of treatment adherence among people with low-literacy living with HIV/AIDS Psychosom Med 72 2010 810 816
10. S. Parashar, A.K. Palmer, and N. O'Brien Sticking to it: the effect of maximally assisted therapy on antiretroviral treatment adherence among individuals living with HIV who are unstably housed AIDS Behav 15 2011 1612 1622
11. M.C. Wong, J.Y. Jiang, and S.M. Griffiths Factors associated with compliance to thiazide diuretics among 8551 Chinese patients J Clin Pharm Ther 36 2011 179 186
12. A. Shimony, D. Zahger, R. Ilia, A. Shalev, and C. Cafri Impact of the community's socioeconomic status on characteristics and outcomes of patients undergoing percutaneous coronary intervention Int J Cardiol 144 2010 379 382
13. J.R. Wu, D.K. Moser, M.L. Chung, and T.A. Lennie Predictors of medication adherence using a multidimensional adherence model in patients with heart failure J Card Fail 14 2008 603 614
14. N.K. Choudhry, J. Avorn, and R.J. Glynn Full coverage for preventive medications after myocardial infarction N Engl J Med 365 2011 2088 2097
15. A. Schedlbauer, P. Davies, and T. Fahey Interventions to improve adherence to lipid lowering medication Cochrane Database Syst Rev 2010 CD004371
16. K. Schroeder, T. Fahey, and S. Ebrahim Interventions for improving adherence to treatment in patients with high blood pressure in ambulatory settings Cochrane Database Syst Rev 2004 CD004804
17. P. Tugwell, M. Petticrew, and E. Kristjansson Assessing equity in systematic reviews: realising the recommendations of the Commission on Social Determinants of Health BMJ 341 2010 c4739
18. S. Al-Aqeel, and J. Al-Sabhan Strategies for improving adherence to antiepileptic drug treatment in patients with epilepsy Cochrane Database Syst Rev 2011 CD008312
19. V. Welch, P. Tugwell, and M. Petticrew How effects on health equity are assessed in systematic reviews of interventions Cochrane Database Syst Rev 2010 MR000028
20. C. Lefebvre, E. Manheimer, and J. Glanville J. Higgins, S. Green, Cochrane handbook for systematic reviews of interventions version 502 (updated September 2009) 2009 The Cochrane Collaboration [Available from www.cochrane-handbook.org The Cochrane Collaboration]
21. J. Higgins, and D. Altman Chapter 8: assessing risk of bias in included studies J. Higgins, S. Green, Cochrane handbook for systematic reviews of interventions version 501 (updated September 2008) 2008 The Cochrane Collaboration Oxford, UK Available from www.cochrane-handbook.org; 2008
22. A. Liberati, D.G. Altman, and J. Tetzlaff The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration PLoS Med 6 2009 e1000100
23. Cochrane handbook for systematic reviews of interventions Available from www.cochrane-handbook.org 2009 The Cochrane Collaboration
24. C.R. Dennison, W.S. Post, and M.T. Kim Underserved urban African American men: hypertension trial outcomes and mortality during 5 years Am J Hypertens 20 2007 164 171
25. H.-R. Han, J. Kim, and K.B. Kim Implementation and success of nurse telephone counseling in linguistically isolated Korean American patients with high blood pressure Patient Educ Couns 80 2010 130 134
26. W.L. Haskell, K. Berra, and E. Arias Multifactor cardiovascular disease risk reduction in medically underserved, high-risk patients Am J Cardiol 98 2006 1472 1479
27. M.J. Krantz, E.P. Havranek, D.K. Haynes, I. Smith, B. Bucher-Bartelson, and C.S. Long Inpatient initiation of beta-blockade plus nurse management in vulnerable heart failure patients: a randomized study J Card Fail 14 2008 303 309
28. A. Gialamas, L.N. Yelland, and P. Ryan Does point-of-care testing lead to the same or better adherence to medication? A randomised controlled trial: the PoCT in General Practice Trial Med J Aust 191 2009 487 491
29. C. Lopez Cabezas, C. Falces Salvador, and D. Cubi Quadrada Randomized clinical trial of a postdischarge pharmaceutical care program vs regular follow-up in patients with heart failure Farm 30 2006 328 342
30. M.D. Murray, J. Young, and S. Hoke Pharmacist intervention to improve medication adherence in heart failure: a randomized trial Ann Intern Med 146 2007 714 725
31. G. Ogedegbe, W. Chaplin, and A. Schoenthaler A practice-based trial of motivational interviewing and adherence in hypertensive African Americans Am J Hypertens 21 2008 1137 1143
32. N.N. Qureshi, J. Hatcher, N. Chaturvedi, and T.H. Jafar Effect of general practitioner education on adherence to antihypertensive drugs: cluster randomised controlled trial BMJ 335 2007 1030
33. R.L. Rothman, R. Malone, B. Bryant, and T.D. Sequist A pharmacist-driven intervention improves diabetes care J Clin Outcomes Manage 12 2005 188 189
34. X. Zang, J. Liu, Y. Chai, F.K.Y. Wong, and Y. Zhao Effect on blood pressure of a continued nursing intervention using chronotherapeutics for adult Chinese hypertensive patients J Clin Nurs 19 2010 1149 1156
35. Y. Zhao, and F.K. Wong Effects of a postdischarge transitional care programme for patients with coronary heart disease in China: a randomised controlled trial J Clin Nurs 18 2009 2444 2455
36. L.A. Cooper, D.L. Roter, and K.A. Carson A randomized trial to improve patient-centered care and hypertension control in underserved primary care patients J Gen Intern Med 26 2011 1297 1304
37. M.Y. Martin, Y.I. Kim, and P. Kratt Medication adherence among rural, low-income hypertensive adults: a randomized trial of a multimedia community-based intervention Am J Health Promot 25 2011 372 378
38. S. Michie, M.M. van Stralen, and R. West The behaviour change wheel: a new method for characterising and designing behaviour change interventions Implement Sci 6 2011 42
39. C. Abraham, and S. Michie A taxonomy of behavior change techniques used in interventions Health Psychol 27 2008 379 387
40. L. Osterberg, and T. Blaschke Adherence to medication. [see comment] N Engl J Med 353 2005 487 497
41. S.L. Cutrona, N.K. Choudhry, and M. Stedman Physician effectiveness in interventions to improve cardiovascular medication adherence: a systematic review J Gen Intern Med 25 2010 1090 1096
42. S. Jan, T. Usherwood, and J.A. Brien What determines adherence to treatment in cardiovascular disease prevention? Protocol for a mixed methods preference study BMJ Open 1 2011 e000372